Metformin Therapy for Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction Versus Pulmonary Arterial Hypertension

Overview

Journal Am J Respir Crit Care Med

Specialty Critical Care

Date 2018 May 5

PMID 29727194

Citations 22

Authors

Dmitry A Goncharov

Elena A Goncharova

Stevan P Tofovic

Jian Hu

Jeff J Baust

Andressa Z Pena

Arnab Ray

Analise Rode

Rebecca R Vanderpool

Ana L Mora

Mark T Gladwin

Yen-Chun Lai

Affiliations

Soon will be listed here.

Citing Articles

Current Overview of the Biology and Pharmacology in Sugen/Hypoxia-Induced Pulmonary Hypertension in Rats.

Corboz M, Nguyen T, Stautberg A, Cipolla D, Perkins W, Chapman R J Aerosol Med Pulm Drug Deliv. 2024; 37(5):241-283.

PMID: 39388691 PMC: 11502635. DOI: 10.1089/jamp.2024.0016.

The role and mechanism of AMPK in pulmonary hypertension.

Hou J, Nie Y, Wen Y, Hua S, Hou Y, He H Ther Adv Respir Dis. 2024; 18:17534666241271990.

PMID: 39136335 PMC: 11322949. DOI: 10.1177/17534666241271990.

Mechanisms and treatment of pulmonary arterial hypertension.

Ghofrani H, Gomberg-Maitland M, Zhao L, Grimminger F Nat Rev Cardiol. 2024; 22(2):105-120.

PMID: 39112561 DOI: 10.1038/s41569-024-01064-4.

Plasma Proteomics Identifies B2M as a Regulator of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction.

Jheng J, DesJardin J, Chen Y, Huot J, Bai Y, Cook T Arterioscler Thromb Vasc Biol. 2024; 44(7):1570-1583.

PMID: 38813697 PMC: 11208054. DOI: 10.1161/ATVBAHA.123.320270.

Novel insights into the pathobiology of pulmonary hypertension in heart failure with preserved ejection fraction.

Aradhyula V, Vyas R, Dube P, Haller S, Gupta R, Maddipati K Am J Physiol Heart Circ Physiol. 2024; 326(6):H1498-H1514.

PMID: 38639739 PMC: 11380948. DOI: 10.1152/ajpheart.00068.2024.

References

Marra A, Arcopinto M, Bossone E, Ehlken N, Cittadini A, Grunig E . Pulmonary arterial hypertension-related myopathy: an overview of current data and future perspectives. Nutr Metab Cardiovasc Dis. 2014; 25(2):131-9. DOI: 10.1016/j.numecd.2014.10.005. View

Agard C, Rolli-Derkinderen M, Dumas-de-La-Roque E, Rio M, Sagan C, Savineau J . Protective role of the antidiabetic drug metformin against chronic experimental pulmonary hypertension. Br J Pharmacol. 2009; 158(5):1285-94. PMC: 2782337. DOI: 10.1111/j.1476-5381.2009.00445.x. View

Paulin R, Dromparis P, Sutendra G, Gurtu V, Zervopoulos S, Bowers L . Sirtuin 3 deficiency is associated with inhibited mitochondrial function and pulmonary arterial hypertension in rodents and humans. Cell Metab. 2014; 20(5):827-839. DOI: 10.1016/j.cmet.2014.08.011. View

Palacios O, Carmona J, Michan S, Chen K, Manabe Y, Ward 3rd J . Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1alpha in skeletal muscle. Aging (Albany NY). 2010; 1(9):771-83. PMC: 2815736. DOI: 10.18632/aging.100075. View

Dean A, Nilsen M, Loughlin L, Salt I, MacLean M . Metformin Reverses Development of Pulmonary Hypertension via Aromatase Inhibition. Hypertension. 2016; 68(2):446-54. DOI: 10.1161/HYPERTENSIONAHA.116.07353. View

Quan H, Zhang H, Wei W, Fang T . Gender-related different effects of a combined therapy of Exenatide and Metformin on overweight or obesity patients with type 2 diabetes mellitus. J Diabetes Complications. 2016; 30(4):686-92. DOI: 10.1016/j.jdiacomp.2016.01.013. View

Dixon D, Trivedi A, Shah S . Combined post- and pre-capillary pulmonary hypertension in heart failure with preserved ejection fraction. Heart Fail Rev. 2015; 21(3):285-97. DOI: 10.1007/s10741-015-9523-6. View

Zuckerbraun B, Shiva S, Ifedigbo E, Mathier M, Mollen K, Rao J . Nitrite potently inhibits hypoxic and inflammatory pulmonary arterial hypertension and smooth muscle proliferation via xanthine oxidoreductase-dependent nitric oxide generation. Circulation. 2009; 121(1):98-109. DOI: 10.1161/CIRCULATIONAHA.109.891077. View

Anisimov V, Piskunova T, Popovich I, Zabezhinski M, Tyndyk M, Egormin P . Gender differences in metformin effect on aging, life span and spontaneous tumorigenesis in 129/Sv mice. Aging (Albany NY). 2010; 2(12):945-58. PMC: 3034183. DOI: 10.18632/aging.100245. View

10.

Lai Y, Tabima D, Dube J, Hughan K, Vanderpool R, Goncharov D . SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction. Circulation. 2016; 133(8):717-31. PMC: 4766041. DOI: 10.1161/CIRCULATIONAHA.115.018935. View

11.

Hansmann G, Wagner R, Schellong S, de Jesus Perez V, Urashima T, Wang L . Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation. Circulation. 2007; 115(10):1275-84. DOI: 10.1161/CIRCULATIONAHA.106.663120. View

12.

Hirschey M, Shimazu T, Jing E, Grueter C, Collins A, Aouizerat B . SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol Cell. 2011; 44(2):177-90. PMC: 3563434. DOI: 10.1016/j.molcel.2011.07.019. View